Adams Street Partners
Adams Street Partners operates as a global private market investment management firm.
Business Model:
Revenue: $10M
Employees: 201-500
Rankings
Detailed Adams Street Partners Information
Geographic Data
Address: 1 N Wacker Dr
City: Chicago
State: IL
Zip: 60606
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$6B
Social
Facebook
Linkedin
Crunchbase
Metrics
2,239,931Website Global Rank
8,559Website Monthly Traffic
Twitter Followers
Description
Adams Street Partners is a global private market investment management firm that offers comprehensive solutions for its investors. As one of the independent, employee-owned firms, Adams Street has established a reputation for strong performance, an extensive knowledge base, and a disciplined investment approach that values quality over quantity. For more than 45 years, Adams Street has gained the experience to successfully manage through some of the most challenging investment cycles. The collective knowledge of the Adams Street team works collaboratively to leverage the global resources of the Firm in navigating the complexities of private markets. Its mission as a premier private markets investment manager is to provide world-class investment performance and maintain the confidence of our investors through our deep understanding of the global private marketplace and deliver exemplary client service.
Contact Phone:
+13125537890
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 4/2007 | Cybera | Series C | 18M |
| 3/2021 | Advise Health | Series A | 100M |
| 11/2011 | BrightRoll | Series D | 20.3M |
| 9/2012 | Damballa | Series E | 15M |
| 6/2014 | Couchbase | Series E | 60M |
| 3/2016 | Couchbase | Series F | 30M |
| 9/2019 | VillageMD | Series B | 100M |
| 7/2022 | ClassDojo | Series D | 125M |
| 5/2017 | Mintigo | Series E | 0 |
| 12/2006 | Setanta | Private Equity Round | 0 |
| 5/2016 | Aptinyx | Series A | 0 |
| 5/2020 | Palvella Therapeutics | Series C | 0 |
| 1/2007 | Ancestry | Funding Round | - |
| 5/2021 | SymphonyRM | Series B | 0 |
| 9/2010 | Solaria | Series D | 65M |
| 7/2014 | LogRhythm | Series E | 40M |
| 8/2013 | CareCloud | Series B | 9M |
| 4/2021 | ThreatQuotient | Venture Round | 0 |
| 3/2004 | Jazz Pharmaceuticals | Series B | 0 |
| 11/2016 | CareCloud | Post-IPO Equity | 0 |
| 6/2001 | Quallaby Corporation | Venture Round | 14.5M |
| 8/2007 | Luminary Micro | Series C | 25M |
| 1/2004 | Borderfree | Series C | 13.8M |
| 1/1999 | Syneos Health | Venture Round | - |
| 12/2022 | BillionToOne | Series C | 0 |
| 4/2023 | Altruist | Series D | 0 |
| 8/2021 | Reify Health | Series C | 220M |
| 6/2004 | Proteus Digital Health | Series B | 6.3M |
| 10/2010 | TriReme Medical | Series D | 17M |
| 1/2002 | Synchronoss Technologies | Series A | 0 |
| 5/2001 | Synchronoss Technologies | Series A | 0 |
| 5/2020 | Couchbase | Series G | 0 |
| 6/2022 | FalconX | Series D | 0 |
| 1/2007 | TicketsNow | Series A | 34M |
| 4/2014 | Telesign | Series B | 40M |
| 7/2020 | Robinhood | Series F | 0 |
| 12/2008 | Jaspersoft | Venture Round | 12.5M |
| 10/2018 | Qpex Biopharma | Series A | 33M |
| 5/2001 | Netcontinuum | Series B | 26M |
| 8/2003 | comScore | Series E | 12M |
| 11/2017 | Outpost Medicine, LLC | Series A | 20M |
| 12/2015 | CBANC | Series B | 4M |
| 1/2012 | Neuraltus Pharmaceuticals | Series B | 9.6M |
| 4/2021 | Mineralys Therapeutics | Series A | 0 |
| 1/2011 | PneumRx | Venture Round | 0 |
| 12/2016 | Tripping.com | Series C | 0 |
| 5/2013 | Atlantis Computing | Series D | 0 |
| 1/2019 | Millennium Trust Co | Venture Round | - |
| 12/2005 | GlobeImmune | Series B | 34.3M |
| 6/2015 | RadiumOne | Series C | 54M |
| 3/2011 | RadiumOne | Series B | 31.5M |
| 8/2013 | Couchbase | Series D | 25M |
| 10/2006 | Enfora | Venture Round | 19M |
| 11/2009 | Zynga | Venture Round | - |
| 12/2012 | Naurex | Series B | 0 |
| 5/2017 | Smule | Series H | 54M |
| 5/2010 | Arroweye Solutions | Private Equity Round | 8.4M |
| 5/2019 | Solera Health | Series C | 0 |
| 4/2019 | Fusion Pharmaceuticals | Series B | 0 |
| 6/2016 | Smule | Series G | 0 |
| 8/2003 | Engim | Series B | 18.5M |
| 12/2017 | Aptinyx | Series B | 70M |
| 3/2016 | Maxwell Health | Series C | 0 |
| 12/2014 | Maxwell Health | Series B | 26.4M |
| 3/2007 | PneumRx | Series B | 0 |
| 10/2021 | Orca Security | Series C | 0 |
| 5/2007 | Convio | Series E | 10.2M |
| 5/2003 | SPS Commerce | Venture Round | 18M |
| 9/2009 | RadiumOne | Series A | 2M |
| 8/2014 | Scytl | Series C | 44M |
| 10/2018 | Arctic Wolf | Series C | 45M |
| 7/2004 | Convio | Series D | 15M |
| 6/2021 | Aircall | Series D | 0 |
| 5/2020 | Aircall | Series C | 0 |
| 11/2011 | Rempex Pharmaceuticals | Series B | 67.5M |
| 9/2014 | BoomTown | Series A | 20.1M |
| 2/2021 | Redox | Series D | 45M |
| 1/2006 | MX Logic | Series E | 6.5M |
| 12/2007 | MX Logic | Series G | 2.7M |
| 11/2008 | MX Logic | Series G | 5.7M |
| 4/2008 | Visible World | Series C | 25M |
| 9/2015 | Corvus Pharmaceuticals | Series B | 75M |
| 2/2008 | Snagajob | Series B | 5M |
| 11/2008 | Arroweye Solutions | Private Equity Round | 23.5M |
| 1/2011 | Five9 | Series C | 8.6M |
| 4/2012 | Five9 | Venture Round | 12M |
| 11/2016 | TrendKite | Series D | 16.3M |
| 3/2014 | ThreatMetrix | Series E | 20M |
| 11/2008 | OncoMed Pharmaceuticals | Series B | 154M |
| 7/2002 | Sensys Medical | Series D | 0 |
| 2/2010 | BrightRoll | Series C | 10M |
| 2/2019 | PerimeterX | Series C | 43M |
| 11/2011 | Pivot Medical | Series C | 32M |
| 6/2015 | Chrome River Technologies | Series D | 100M |
| 12/2014 | Naurex | Series C | 0 |
| 5/2007 | Arroweye Solutions | Series C | 14M |
| 10/2007 | TriReme Medical | Series C | 15.5M |
| 5/2020 | Homeward | Series A | 20M |
| 5/2021 | Homeward | Series B | 136M |
| 2/2005 | Aesthera Corporation | Series B | 6.5M |
| 8/2015 | Apto | Series B | 8M |
| 3/2017 | TurnKey Vacation Rentals | Series C | 21M |
| 3/2018 | TurnKey Vacation Rentals | Series D | 31M |
| 7/2006 | Snagajob | Series A | 9M |
| 4/2017 | Cirius Therapeutics | Series A | 0 |
| 6/2014 | Visier | Series C | 25.5M |
| 6/2017 | MyHealthTeams | Series A | 7.3M |
| 12/2017 | Atox Bio | Series F | 0 |
| 7/2011 | Adesto Technologies | Series C | 17.4M |
| 2/2018 | Cofense | Venture Round | - |
| 6/2022 | Mineralys Therapeutics | Series B | 0 |
| 9/2019 | PerimeterX | Series C | 0 |
| 3/2003 | Livevault | Series B | 10M |
| 3/2011 | LogRhythm | Series C | 10M |
| 6/2012 | LogRhythm | Series D | 15M |
| 9/2004 | MX Logic | Series D | 8M |
| 5/2004 | PathScale | Series C | 15M |
| 12/2019 | Epirium Bio | Series A | 0 |
| 9/2021 | Nomad Health | Series D | 0 |
| 9/2009 | Actelis Networks | Venture Round | 0 |
| 1/2007 | FarmLink | Venture Round | 0 |
| 5/2012 | Cybera | Venture Round | 4.4M |
| 1/2012 | Donuts | Series A | 0 |
| 2/2019 | GoCardless | Series E | 75M |
| 8/2018 | Cirius Therapeutics | Series A | 9M |
| 3/2016 | Outpost Medicine | Series A | 41M |
| 2/2017 | Scytl | Series D | 13M |
| 11/2019 | Punchh | Series C | 40M |
| 2/2014 | MyHealthTeams | Series A | 3.4M |
| 8/2021 | Hopin | Series D | 0 |
| 2/2002 | Livevault | Venture Round | 8M |
| 7/2017 | Lever | Series C | 40M |
| 8/2001 | comScore | Series C | 15M |
| 9/2003 | Quallaby Corporation | Series E | 5M |
| 11/2022 | DispatchHealth | Series E | 330M |
| 8/2012 | MyHealthTeams | Seed Round | 1.8M |
| 4/2014 | Boundary | Series C | 22M |
| 2/2009 | Mpex Pharmaceuticals | Series D | 27.5M |
| 2/2006 | Cybera | Venture Round | 12.8M |
| 11/2016 | CareCloud Corporation | Series C | 31.5M |
| 3/2017 | Visier | Series D | 0 |
| 11/2015 | Earnest | Series B | 75M |
| 3/2013 | Q2ebanking | Series C | 20M |
| 4/2022 | Reify Health | Series D | 220M |
| 2/2018 | Dynamic Signal | Series E | 0 |
| 4/2021 | ThreatQuotient | Debt Financing | 0 |
| 1/2022 | Dremio | Series E | 0 |
| 1/2016 | healthfinch | Series A | 7.5M |
| 2/2021 | PerimeterX | Series D | 0 |
| 10/2005 | Light Sciences Oncology | Series A | 35M |
| 9/2017 | Fusion Pharmaceuticals | Series A | 0 |
| 7/2004 | Danger | Series D | 37M |
| 1/2004 | E4 X Inc | Series C | 0 |
| 7/2012 | Borderfree | Series E | 0 |
| 6/2010 | Adesto Technologies | Venture Round | 3.5M |
| 5/2011 | Naurex | Series A | 18M |
| 6/2022 | Nomad Health | Venture Round | 0 |
| 12/2010 | RetailMeNot | Series B | 90M |
| 8/2010 | YouSendIt | Series D | 15M |
| 11/2013 | Hightail | Series E | 0 |
| 1/2018 | MATRIXX Software | Series C | 0 |
| 4/2021 | Icosavax | Series B | 0 |
| 11/2017 | ThreatQuotient | Series C | 30M |
| 4/2014 | Damballa | Series E | 13M |
| 3/2022 | BillionToOne | Series C | 0 |
| 8/2019 | MyHealthTeams | Series B | 0 |
| 11/2015 | MyHealthTeams | Series A | 5M |
| 3/2011 | Snagajob | Series C | 27M |
| 8/2001 | Myogen | Series D | 52.4M |
| 8/2018 | Millendo Therapeutics | Venture Round | 30M |
| 1/2016 | Millendo Therapeutics | Series B | 0 |
| 9/2012 | Criteo | Series D | 40M |
| 4/2015 | Smule | Series F | 26M |
| 6/2021 | Visier | Series E | 125M |
| 4/2022 | Remote | Series C | 0 |
| 6/2002 | comScore | Series D | 20M |
| 4/2010 | Amonix | Series B | 0 |
| 11/2007 | RadPharm | Series B | 10M |
| 6/2021 | Iterable | Series E | 0 |
| 3/2009 | Neuraltus Pharmaceuticals | Series A | 17M |
| 6/2010 | Incline Therapeutics | Series A | 43M |
| 11/2016 | Sauce Labs | Venture Round | 70M |
| 1/2015 | Yeahka | Venture Round | - |
| 8/2005 | Mpex Pharmaceuticals | Series B | 0 |
| 2/2010 | WebVisible | Series C | 20M |
| 11/2012 | ServiceMax | Series D | 27M |
| 7/2017 | Solera Health | Series B | 18.3M |
| 7/2007 | Stratavia | Series B | 6.3M |
| 8/2005 | Stratavia | Series A | 3.3M |
| 11/2014 | Bluprint | Series D | 50M |
| 1/2004 | Aesthera Corporation | Series A | 2.5M |
| 10/2011 | MATRIXX Software | Series B | 12M |
| 1/2002 | CBeyond | Venture Round | - |
| 9/2015 | Cybera | Private Equity Round | - |
| 8/2016 | LogRhythm | Venture Round | 50M |
| 8/2013 | CareCloud Corporation | Series B | 9M |
| 6/2001 | SPS Commerce | Series D | 10M |
| 5/2017 | Snow Software | Venture Round | - |
| 1/2017 | Included Health (previously Grand Rounds Health and Doctor On Demand) | Venture Round | - |
| 10/2019 | Icosavax | Series A | 0 |
| 4/2012 | Neuraltus Pharmaceuticals | Venture Round | 0 |
| 1/2010 | magicJack | Venture Round | - |
| 5/2007 | ShermansTravel Media, LLC | Private Equity Round | 14M |
| 5/2009 | Peerless Network | Venture Round | 10.1M |
| 3/2006 | RadPharm | Series A | 8M |
| 1/2016 | Skybox Security | Venture Round | - |
| 5/2009 | Revascular Therapeutics | Series B | 3M |
| 1/2018 | Therapy Brands | Venture Round | - |
| 8/2015 | Orbus Therapeutics | Series A | 32.5M |
| 5/2008 | Paylocity | Venture Round | 10M |
| 12/2013 | Bluprint | Series C | 35M |
| 3/2007 | WhiteFence | Series B | 0 |
| 5/2013 | Five9 | Series D | 22M |
| 2/2018 | Partner Therapeutics | Series A | 60M |
| 12/2005 | Light Sciences Oncology | Series A | 32M |
| 5/2019 | SymphonyRM | Series A | 10M |
| 7/2011 | Jaspersoft | Unattributed | 11M |
| 1/2007 | DolEx Dollar Express | Venture Round | - |
| 2/2006 | Aesthera Corporation | Series C | 11M |
| 6/2009 | Integral Development Corp | Venture Round | 11M |
| 11/2006 | MX Logic | Series F | 4M |
| 7/2019 | TurnKey Vacation Rentals | Series E | 48M |
| 1/2007 | Actelis Networks | Series E | 22M |
| 4/2011 | Spiceworks, Inc. | Series D | 25M |
| 2/2014 | Spiceworks, Inc. | Series E | 57M |
| 10/2013 | Mintigo | Series C | 10M |
| 9/2008 | Sportgenic | Series B | 10M |
| 6/2007 | WiQuest Communications | Series C | 28M |
| 7/2022 | ClassDojo | Series D | 0 |
| 6/2022 | Nomad Health | Venture Round | 0 |
| 6/2022 | FalconX | Series D | 0 |
| 6/2022 | Mineralys Therapeutics | Series B | 0 |
| 4/2022 | Reify Health | Series D | 0 |
| 4/2022 | Remote | Series C | 0 |
| 3/2022 | BillionToOne | Series C | 0 |
| 1/2022 | Dremio | Series E | 0 |
| 10/2021 | Orca Security | Series C | 0 |
| 9/2021 | Nomad Health | Series D | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
